BioPhorum member only benchmarking exercise seeking member experience on expectations for mycoplasma testing of cell therapies.
Adventitious virus and mycoplasma
Viewing related articles
A BioPhorum member survey examining approaches to testing allogenic cell therapies for adventitious viral contaminants.
Alternative adventitious agent detection methods in biopharmaceuticals: A proposal for a structured best practice approach for their evaluation, validation, and implementation
This paper addresses the need for a systematic and best practice approach to the evaluation, validation and implementation of these methods related to adventitious agents testing to support the adoption of alternative adventitious agent testing (AAT) methods. A nine-step framework and common language are described which can be applied by biopharmaceutical companies wanting to take advantage of the numerous benefits of ARMMs and alternative AATs.